safingol and Aortic Diseases

safingol has been researched along with Aortic Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hanselman, JC; Homan, R; Karathanasis, SK; Kindt, EK; Mueller, SB; Panek, RL; Park, TS; Rekhter, MD; Robertson, AW; Rosebury, WS	1

Other Studies

1 other study(ies) available for safingol and Aortic Diseases

Article	Year
Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice. Circulation, 2004, Nov-30, Volume: 110, Issue:22 Topics: Acyltransferases; Animals; Aorta; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cholesterol; Chromatography, High Pressure Liquid; Diet, Atherogenic; Drug Evaluation, Preclinical; Enzyme Induction; Fatty Acids, Monounsaturated; Hyperlipoproteinemia Type II; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phospholipids; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Serine C-Palmitoyltransferase; Sphingomyelins; Sphingosine; T-Lymphocytes; Triglycerides	2004

Article

Year

Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.

Circulation, 2004, Nov-30, Volume: 110, Issue:22

Topics: Acyltransferases; Animals; Aorta; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cholesterol; Chromatography, High Pressure Liquid; Diet, Atherogenic; Drug Evaluation, Preclinical; Enzyme Induction; Fatty Acids, Monounsaturated; Hyperlipoproteinemia Type II; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phospholipids; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Serine C-Palmitoyltransferase; Sphingomyelins; Sphingosine; T-Lymphocytes; Triglycerides

2004